|6.10||-0.25 / -3.94%|
As of 4:00pm ET
|6.10||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 9.00. The median estimate represents a +63.93% increase from the last price of 6.10.
The current consensus among 6 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.